Elliott Richelson
#105,303
Most Influential Person Now
Elliott Richelson's AcademicInfluence.com Rankings
Elliott Richelsonmedical Degrees
Medical
#1305
World Rank
#1631
Historical Rank
Pharmacology
#96
World Rank
#125
Historical Rank
Download Badge
Medical
Elliott Richelson's Degrees
- PhD Pharmacology University of California, San Francisco
- Doctorate Medicine Stanford University
Why Is Elliott Richelson Influential?
(Suggest an Edit or Addition)Elliott Richelson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pharmacological profile of antidepressants and related compounds at human monoamine transporters. (1997) (855)
- Bupropion: a review of its mechanism of antidepressant activity. (1995) (733)
- Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. (2000) (657)
- Neurotransmitter Synthesis by Neuroblastoma Clones (1972) (620)
- Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. (1984) (539)
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. (1993) (391)
- Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. (1984) (312)
- Receptor pharmacology of neuroleptics: relation to clinical effects. (1999) (309)
- Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: Clinical Predictors of Outcome in a Multisite, Randomized Controlled Clinical Trial (2009) (282)
- Mood and cognitive side effects of interferon-α therapy (1998) (272)
- Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. (1992) (271)
- Pharmacology of antidepressants. (2001) (251)
- Pharmacology of antidepressants--characteristics of the ideal drug. (1994) (239)
- Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. (1984) (222)
- Binding of antidepressants to human brain receptors: focus on newer generation compounds (1994) (192)
- Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. (2006) (184)
- Perturbation of upper gastrointestinal function by cold stress. (1983) (184)
- Biochemical differentiation of mechanically dissociated mammalian brain in aggregating cell culture (1976) (183)
- Contulakin-G, an O-Glycosylated Invertebrate Neurotensin* (1999) (168)
- Tricyclic antidepressants and histamine H1 receptors. (1979) (157)
- Mood and cognitive side effects of interferon-alpha therapy. (1998) (152)
- Neurotensin: peptide for the next millennium (2000) (150)
- Neurotransmitter receptors mediate cyclic GMP formation by involvement of arachidonic acid and lipoxygenase. (1984) (145)
- The Concise Guide to Pharmacology 2013/14: Overview (2013) (143)
- Preclinical pharmacology of neuroleptics: focus on new generation compounds. (1996) (142)
- Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. (1997) (137)
- Neuroleptic affinities for human brain receptors and their use in predicting adverse effects. (1984) (136)
- Perturbation of gastric emptying and duodenal motility through the central nervous system. (1982) (136)
- Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. (1999) (121)
- Synaptic Effects of Antidepressants (1996) (121)
- The coupling of the neuronal muscarinic receptor to responses. (1984) (114)
- Morphological differentiation of mechanically dissociated fetal rat brain in aggregating cell cultures (1979) (114)
- Pharmacology of antidepressants in use in the United States. (1982) (112)
- Serum Anticholinergic Activity in Hospitalized Older Persons with Delirium: A Preliminary Study (1995) (109)
- Tricyclic antidepressants block histamine H1 receptors of mouse neuroblastoma cells (1978) (101)
- Matrix metalloproteinase-9 contributes to brain extravasation and edema in fulminant hepatic failure mice. (2006) (97)
- Antidepressants : neurochemical, behavioral, and clinical perspectives (1981) (97)
- Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance. (2003) (97)
- Diverse Roles of Neurotensin Agonists in the Central Nervous System (2013) (95)
- Muscarinic m4 receptor activation by some atypical antipsychotic drugs. (1997) (95)
- Stimulation of tyrosine hydroxylase activity in an adrenergic clone of mouse neuroblastoma by dibutyryl cyclic AMP. (1973) (93)
- Pharmacological profile of neuroleptics at human monoamine transporters. (1999) (91)
- Transport of neurotransmitter precursors into cultured cells. (1973) (89)
- The pharmacology of antidepressants at the synapse: focus on newer compounds. (1994) (88)
- Analysis of the distribution of erythrocyte sodium lithium countertransport in a sample representative of the general population (1986) (88)
- Lithium ion entry through the sodium channel of cultured mouse neuroblastoma cells: a biochemical study. (1977) (86)
- Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. (2002) (86)
- Neurotensin stimulates formation of cyclic GMP in murine neuroblastoma clone N1E-115. (1984) (84)
- Neurotensin Stimulates Inositol Phospholipid Metabolism and Calcium Mobilization in Murine Neuroblastoma Clone N1E‐115 (1986) (84)
- Highly potent neurotensin analog that causes hypothermia and antinociception. (2000) (84)
- Long-term regulation of muscarinic acetylcholine receptors on cultured nerve cells. (1979) (83)
- Histamine H1 receptor-mediated guanosine 3',5'-monophosphate formation by cultured mouse neuroblastoma cells. (1978) (83)
- Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo (1998) (81)
- Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem (1991) (80)
- Histamine H1 receptors in human brain labelled with [3H]Doxepin (1984) (80)
- Muscarinic receptor-mediated cyclic GMP formation by cultured nerve cells--ionic dependence and effects of local anesthetics. (1978) (77)
- Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics. (1993) (76)
- Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells. (1991) (76)
- Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol (2000) (73)
- Antimuscarinic and other receptor-blocking properties of antidepressants. (1983) (73)
- Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications. (2013) (71)
- Biochemical differentiation of aggregating cell cultures of different fetal rat brain regions (1977) (71)
- Pharmacology of neuroleptics in use in the United States. (1985) (70)
- Proposed Ligand Binding Site of the Transmembrane Receptor for Neurotensin(8–13)* (1996) (69)
- Properties of monoamine oxidase in mouse neuroblastoma N1E-115 cells. (1976) (67)
- Biological basis of depression and therapeutic relevance. (1991) (66)
- Antagonism by antidepressants of serotonin S1 and S2 receptors of normal human brain in vitro. (1986) (64)
- Desensitisation of muscarinic receptor-mediated cyclic GMP formation by cultured nerve cells (1978) (63)
- Bioactive analogs of neurotensin: Focus on CNS effects (2006) (61)
- In vitro binding and CNS effects of novel neurotensin agonists that cross the blood–brain barrier (1999) (60)
- A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity. (2001) (60)
- Mechanism of mesenchymal stem cell-induced neuron recovery and anti-inflammation. (2014) (59)
- Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro. (1987) (59)
- Neurotransmitter synthesis by neuroblastoma clones (neuroblast differentiation-cell culture-choline acetyltransferase-acetylcholinesterase-tyrosine hydroxylase-axons-dendrites). (1972) (59)
- Sodium-lithium countertransport and blood pressure in healthy blood donors. (1985) (59)
- Blockade by psychotropic drugs of the muscarinic acetylcholine receptor in cultured nerve cells. (1977) (58)
- Studies on Muscarinic Binding Sites in Human Brain Identified with [3H]Pirenzepine (1986) (58)
- Binding of [3H]Neurotensin in Human Brain: Properties and Distribution (1986) (57)
- Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain. (1983) (57)
- Antidepressants and brain neurochemistry. (1990) (56)
- REGULATION OF TYROSINE HYDROXYLASE ACTIVITY IN MOUSE NEUROBLASTOMA CLONE N1E‐115 (1973) (55)
- Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations. (1985) (53)
- SUBSTRATE AND INHIBITOR‐RELATED CHARACTERISTICS OF MONOAMINE OXIDASE IN C6 RAT GLIAL CELLS (1976) (53)
- Antidepressant-Like Pharmacological Profile of a Novel Triple Reuptake Inhibitor, (1S,2S)-3-(Methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS) (2008) (52)
- A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents (2000) (51)
- Effects of Amitriptyline on Gastric Sensorimotor Function and Postprandial Symptoms in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Trial (2008) (51)
- The neurotensin receptor: is there more than one subtype? (1996) (50)
- Sodium nitroprusside-induced apoptotic cellular death via production of hydrogen peroxide in murine neuroblastoma N1E-115 cells. (1996) (49)
- Neurotransmitter synthesis, storage and release by aggregating cell cultures of rat brain (1979) (49)
- Acute effect of ethanol on prostaglandin E1-mediated cyclic AMP formation by a murine neuroblastoma clone. (1982) (49)
- Neurotensin and its analogs--correlation of specific binding with stimulation of cyclic GMP formation in neuroblastoma clone N1E-115. (1986) (48)
- Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050. (2007) (48)
- Evaluation of organic cation transporter 3 (SLC22A3) inhibition as a potential mechanism of antidepressant action. (2012) (48)
- High affinity binding of tricyclic antidepressants to histamine H1-receptors: fact and artifact. (1980) (47)
- Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells. (1994) (47)
- The Rat Neurotensin Receptor Expressed in Chinese Hamster Ovary Cells Mediates the Release of Inositol Phosphates (1992) (46)
- Paliperidone as a mood stabilizer: A pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression (2008) (46)
- The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition (2003) (46)
- Psychedelic drugs: steric factors that predict psychotropic activity. (1968) (45)
- Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys (2005) (45)
- NT79: A novel neurotensin analog with selective behavioral effects (2010) (44)
- Multi-modality: a new approach for the treatment of major depressive disorder (2013) (43)
- Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group. (1998) (43)
- Evidence for a role of NTS2 receptors in the modulation of tonic pain sensitivity (2009) (43)
- Neurotensin stimulates cyclic AMP formation in CHO-rNTR-10 cells expressing the cloned rat neurotensin receptor. (1993) (43)
- The molecular basis of neurotransmission at the muscarinic receptor. (1981) (42)
- Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice (2010) (42)
- Pharmacological and Biochemical Profiles of Unique Neurotensin 8-13 Analogs Exhibiting Species Selectivity, Stereoselectivity, and Superagonism (*) (1995) (42)
- Spinal NTS1 receptors regulate nociceptive signaling in a rat formalin tonic pain model (2008) (42)
- High-affinity binding of [3H]doxepin to histamine H1-receptors in rat brain: possible identification of a subclass of histamine H1-receptors. (1982) (41)
- Temperature Dependence of Muscarinic Acetylcholine Receptor Activation, Desensitization, and Resensitization (1980) (40)
- Evidence for additional neurotensin receptor subtypes: neurotensin analogs that distinguish between neurotensin-mediated hypothermia and antinociception (1998) (40)
- Identification of a polymorphism in the human neurotensin receptor gene. (1993) (40)
- The newer antidepressants: structures, pharmacokinetics, pharmacodynamics, and proposed mechanisms of action. (1984) (39)
- Desensitization of histamine H1 receptor-mediated cyclic GMP formation in mouse neuroblastoma cells. (1979) (39)
- Tricyclic antidepressants: potent blockade of histamine H1 receptors of guinea pig ileum. (1979) (39)
- In vivo studies with low doses of levocabastine and diphenhydramine, but not pyrilamine, antagonize neurotensin-mediated antinociception (1998) (37)
- Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. (2003) (37)
- Thrombin stimulation of guanosine 3',5'-monophosphate formation in murine neuroblastoma cells (clone N1E-115). (1983) (37)
- Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients (1991) (37)
- Characterization of the Genomic Structure, Promoter Region, and a Tetranucleotide Repeat Polymorphism of the Human Neurotensin Receptor Gene* (1997) (37)
- Desensitization and down-regulation of neurotensin receptors in murine neuroblastoma clone N1E-115 by [D-Lys8] neurotensin(8-13). (1993) (37)
- Thrombin binding to human brain and spinal cord. (1983) (36)
- Effect of Some Calcium Antagonists on Muscarinic Receptor‐Mediated Cyclic GMP Formation (1983) (35)
- Pharmacology of antidepressants. (2001) (35)
- Involvement of calcium channels in short-term desensitization of muscarinic receptor-mediated cyclic GMP formation in mouse neuroblastoma cells. (1980) (35)
- Novel neurotensin analog blocks the initiation and expression of nicotine-induced locomotor sensitization (2003) (35)
- Comparison of the stimulation of inositol phospholipid hydrolysis and of cyclic GMP formation by neurotensin, some of its analogs, and neuromedin N in neuroblastoma clone N1E-115. (1987) (34)
- Elucidating the Role of Neurotensin in the Pathophysiology and Management of Major Mental Disorders (2014) (33)
- Pharmacokinetic interactions of antidepressants. (1998) (33)
- Effects of chronic exposure to ethanol on the prostaglandin E1 receptor-mediated response and binding in a murine neuroblastoma clone (N1E-115). (1986) (33)
- Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an α1 agonist (2004) (33)
- Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats. (2001) (32)
- Tricyclic Antidepressants and Neurotransmitter Receptors (1979) (32)
- The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex (2010) (32)
- Antipsychotics block muscarinic acetylcholine receptor-mediated cyclic GMP formation in cultured mouse neuroblastoma cells (1977) (31)
- Treatment of acute depression. (1993) (31)
- Antidepressants are weak competitive antagonists of histamine H2 receptors in dissociated brain tissue. (1983) (31)
- Neurotensin receptor type 1 regulates ethanol intoxication and consumption in mice (2010) (30)
- Methionine-enkephalin immunoreactivity in fetal rat brain cells in aggregating culture and in mouse neuroblastoma cells (1980) (30)
- Antipsychotic agents: a clinical update. (1985) (30)
- Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain (1995) (30)
- New Model of Action for Mood Stabilizers: Phosphoproteome from Rat Pre-Frontal Cortex Synaptoneurosomal Preparations (2013) (29)
- Neurotensin analogs indications for use as potential antipsychotic compounds. (2002) (29)
- NT69L, a novel analgesic, shows synergy with morphine (2009) (29)
- Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain (2008) (29)
- Neurotensin agonists: possible drugs for treatment of psychostimulant abuse. (2003) (28)
- Sodium-lithium countertransport in ambulatory hypertensive and normotensive patients. (1987) (28)
- A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats (2011) (27)
- NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain (2012) (27)
- Function and regulation of methionine5-enkephalin and its receptors in murine neuroblastoma cells. (1982) (27)
- Neurotensin Agonists (2007) (27)
- Failure to confirm muscarinic receptors on skin fibroblasts. (1985) (27)
- Phenytoin action on the excitable membrane of mouse neuroblastoma. (1979) (27)
- Synthesis of (2S)-2-amino-3-(1H-4-indolyl)propanoic acid, a novel tryptophan analog for structural modification of bioactive peptides (1998) (27)
- Synthesis and biological studies of novel neurotensin(8-13) mimetics. (2002) (26)
- Neurotensin agonists as an alternative to antipsychotics (2005) (26)
- Studies on the transport of L-tyrosine into an adrenergic clone of mouse neuroblastoma. (1974) (26)
- Organic causes of mania. (1988) (26)
- The clinical relevance of antidepressant interaction with neurotransmitter transporters and receptors. (2002) (26)
- Current topics: brain penetrating neurotensin analog. (2003) (26)
- Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain (2012) (25)
- Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2. (2011) (25)
- Neurotensin analog NT69L induces rapid and prolonged hypothermia after hypoxic ischemia. (2001) (25)
- Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation. (1986) (25)
- The effect of angiotensins I, II, and III on formation of cyclic GMP in murine neuroblastoma clone N1E-115. (1984) (24)
- Neurotensin(8-13): comparison of novel analogs for stimulation of cyclic GMP formation in neuroblastoma clone N1E-115 and receptor binding to human brain and intact N1E-115 cells. (1989) (24)
- Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2. (1995) (24)
- Neurotensin analog NT77 induces regulated hypothermia in the rat. (2003) (24)
- N-substituted cyclopropylamines as inhibitors of MAO-A and -B forms. (1978) (24)
- Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood–brain barrier (2003) (24)
- Selective blockade of receptor-mediated cyclic GMP formation in N1E-115 neuroblastoma cells by an inhibitor of nitric oxide synthesis. (1990) (23)
- Neuroleptic Binding to Human Brain Receptors: Relation to Clinical Effects a (1988) (23)
- Ionic excitation of a clone of mouse neuroblastoma (1975) (23)
- Neurotensin analog selective for hypothermia over antinociception and exhibiting atypical neuroleptic-like properties (2001) (22)
- Antidepressants: a clinical update for medical practitioners. (1984) (22)
- Developmental regulation of neurotensin receptor expression and function in murine neuroblastoma clone N1E-115. (1991) (22)
- Association of bacteriophage proteins and RNA in E. coli infected with MS2. (1967) (22)
- Are receptor studies useful for clinical practice? (1983) (22)
- The protein kinase C activator, 12-O-tetradecanoylphorbol-13-acetate (TPA), inhibits muscarinic (M1) receptor-mediated inositol phosphate release and cyclic GMP formation in murine neuroblastoma cells (clone N1E-115). (1986) (22)
- Lithium ions have a potent and selective inhibitory effect on cyclic GMP formation stimulated by neurotensin, angiotensin II and bradykinin. (1986) (21)
- Neuroleptics and Neurotransmitter Receptors (1980) (21)
- Peptide nucleic acids specifically cause antigene effects in vivo by systemic injection. (2002) (20)
- New antipsychotic drugs: how do their receptor-binding profiles compare? (2010) (20)
- Considerations on safety concerns about citalopram prescribing. (2012) (20)
- Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation. (1984) (20)
- Histamine-induced intracellular free Ca++, inositol phosphates and electrical changes in murine N1E-115 neuroblastoma cells. (1988) (20)
- Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortex in vitro. (1991) (20)
- Kainic acid alters neurochemical development in fetal rat brain aggregating cell cultures (1977) (19)
- Using peptide nucleic acids as gene-expression modifiers to reduce β-amyloid levels (2002) (19)
- Analgesic synergy of neurotensin receptor subtype 2 agonist NT79 and morphine (2011) (19)
- Phenoxybenzamine and dibenamine interactions with calcium channel effectors of the muscarinic receptor. (1981) (19)
- Lithium ion accumulation by cultured glioma cells (1979) (19)
- Cardiovascular effects of neurotensin and some analogues on rats. (1990) (18)
- Further characterization of neurotensin receptor desensitization and down-regulation in clone N1E-115 neuroblastoma cells. (1993) (18)
- Chimeric Rat/Human Neurotensin Receptors Localize a Region of the Receptor Sensitive to Binding of a Novel, Species-specific, Picomolar Affinity Peptide* (1996) (18)
- Similarities in the behavior and molecular deficits in the frontal cortex between the neurotensin receptor subtype 1 knockout mice and chronic phencyclidine-treated mice: Relevance to schizophrenia (2010) (18)
- Histamine H1 receptors in the brain and spinal cord of the cat (1982) (18)
- Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine. (1988) (18)
- Desensitization of neurotensin receptor-mediated cyclic GMP formation in neuroblastoma clone N1E-115. (1988) (18)
- Potentiation by a sodium channel activator of effects of lithium ion on cyclic AMP, cyclic GMP and inositol phosphates (1991) (17)
- Demonstration of a muscarinic receptor-mediated cyclic GMP-dependent hyperpolarization of the membrane potential of mouse neuroblastoma cells using [3H]tetraphenylphosphonium. (1981) (17)
- Glucocorticoids Potentiate the Prostaglandin E1‐Mediated Cyclic AMP Formation by a Cultured Murine Neuroblastoma Clone (1985) (17)
- Antimuscarinic effects of lithium. (1984) (17)
- A method for radioligand binding assays using a robotic workstation. (1993) (17)
- Lithium ion transport by erythrocytes of randomly selected blood donors and manic-depressive patients: lack of association with affective illness. (1986) (17)
- Thrombin binding and stimulation of cyclic guanosine monophosphate formation in neuroblastoma cells. (1986) (17)
- LANT-6, xenopsin and neuromedin N stimulate cyclic GMP at neurotensin receptors. (1986) (17)
- Blockade of N1E-115 murine neuroblastoma muscarinic receptor function by agents that affect the metabolism of arachidonic acid. (1986) (16)
- Altering behavioral responses and dopamine transporter protein with antisense peptide nucleic acids. (2001) (16)
- Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance (2010) (16)
- Down-regulation of amyloid precursor protein by peptide nucleic acid in vivo (2007) (16)
- Activation of cyclic nucleotide formation in murine neuroblastoma N1E-115 cells by modified human thrombins. (1984) (16)
- Pharmacological studies on novel neurotensin mimetics: discovery of a pharmacologically unique agent exhibiting concentration-dependent dual effects as antagonist and agonist. (1993) (15)
- Inhibition by ethanol of forskolin-stimulated adenylate cyclase in a murine neuroblastoma clone (N1E-115). (1985) (15)
- Intraperitoneal injection of antisense peptide nucleic acids targeted to the mu receptor decreases response to morphine and receptor protein levels in rat brain (2001) (15)
- Desensitization of muscarinic M1 receptors of murine neuroblastoma cells (clone N1E-115) without receptor down-regulation and protein kinase C activity. (1990) (15)
- A microwell assay method for the biochemical study of cultured cells. (1973) (14)
- Acute effects of ethanol and other short-chain alcohols on the guanylate cyclase system of murine neuroblastoma cells (clone N1E-115). (1986) (14)
- The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia (2011) (14)
- Systemically and Topically Active Antinociceptive Neurotensin Compounds (2010) (14)
- Lithium transport by mouse neuroblastoma cells (1981) (14)
- Low levels and lack of function of muscarinic binding sites in human skin fibroblasts from five affectively ill patients and two control subjects. (1986) (13)
- Regulation of neurotensin receptor mRNA expression by the receptor antagonist SR 48692 in the rat midbrain dopaminergic neurons. (1995) (13)
- Changes in the sensitivity of receptors for neurotransmitters and the actions of some psychotherapeutic drugs. (1982) (13)
- Effects of lanthanides on muscarinic acetylcholine receptor function. (1981) (13)
- Selectivity of antimuscarinic compounds for muscarinic receptors of human brain and heart (2005) (13)
- The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat (2007) (13)
- Synthesis of (S)- and (R)-enantiomers of p-(4-hydroxybenzoyl)phenylalanine, useful photoaffinity labeling probes for peptide–protein binding sites (1998) (12)
- Role of signal transduction systems in neurotensin receptor down-regulation induced by agonist in murine neuroblastoma clone N1E-115 cells. (1993) (12)
- Lanthanum Binding to Murine Neuroblastoma Cells (1983) (12)
- The implications for antidepressant therapy of measurement of urinary MHPG. (1982) (12)
- Inhibition by Lithium of Cyclic GMP Formation without Inhibition of Nitric Oxide Generation in the Mouse Neuroblastoma Cell (N1E-115) (1994) (12)
- The use of tricyclic antidepressants in chronic gastrointestinal pain. (1982) (11)
- Neuroleptic binding to muscarinic M2 receptors of normal human heart in vitro and comparison with binding to M1 and dopamine D2 receptors of brain (1991) (11)
- Triple reuptake inhibitors: Next-generation antidepressants (2008) (11)
- Antipsychotic drugs: prediction of side-effect profiles based on neuroreceptor data derived from human brain tissue. (1987) (11)
- Regulation of tyrosine hydroxylase activity in mouse neuroblastoma clone N1E-115 (1973) (10)
- Diphenylhydantoin inhibits ionic excitation of mouse neuroblastoma cells (1975) (10)
- Effects of 5 daily injections of the neurotensin-mimetic NT69L on the expression of neurotensin receptors in rat brain. (2005) (10)
- Tissue Culture of the Nervous System: Applications in Neurochemistry and Psychopharmacology (1975) (10)
- Series on pharmacology in practice: 1. Drugs that alter mood. I. Tricyclic agents and monoamine oxidase inhibitors. (1979) (10)
- The expression of mRNA for a kappa opioid receptor in the substantia nigra of Parkinson's disease brain. (1997) (10)
- Affinity of neuroleptics for D1 receptor of human brain striatum. (1994) (10)
- The use of cultured cells in the study of mood-normalizing drugs. (1990) (10)
- Neuropharmacology of zotepine, an antimanic drug: a potent blocker of D2 and 5-HT2 receptors of human brain. (1991) (10)
- Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: A possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia (2010) (10)
- Muscarinic Receptor Regulation of Cyclic GMP and Eicosanoid Production (1989) (9)
- Spinal opiate administration for chronic pain: a major advance in therapy. (1981) (9)
- Regulation of daily rhythm of body temperature by neurotensin receptor in rats. (1995) (9)
- Design, synthesis and pharmacological evaluation of active pyrrole based, nonpeptidic analogues of neurotensin(8-13) (1997) (9)
- Function of delta opioid receptors in cultured cells (2004) (9)
- Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L (2010) (9)
- Hallucinogens antagonize histamine H1 receptors of cultured mouse neuroblastoma cells. (1979) (9)
- Neurobiologic basis of nicotine addiction and psychostimulant abuse: a role for neurotensin? (2005) (9)
- Block of neurotensin receptor down-regulation by an aminosteroid in N1E-115 cells. (1992) (9)
- PROPERTIES OF TYROSINE HYDROXYLATION IN LIVING MOUSE NEUROBLASTOMA CLONE N1E‐115 (1976) (9)
- NT69L blocks ethanol-induced increase of dopamine and glutamate levels in striatum of mouse (2011) (9)
- Kinetic Effects of Terbium Ions on Muscarinic Acetylcholine Receptors of Murine Neuroblastoma Cells (1984) (8)
- Effects of repeated injections of the neurotensin analog NT69L on dopamine release and uptake in rat striatum in vitro (2004) (8)
- Synthesis of partial nonpeptidic peptide mimetics as potential neurotensin agonists and antagonists (1995) (8)
- The Culture of Established Clones for Neurobiologic Investigation (1975) (8)
- Herbal medicines for neuropsychiatric diseases : current developments and research (1999) (8)
- Analysis of binding sites and efficacy of a species-specific peptide at rat and human neurotensin receptors. (2000) (8)
- Anticholinergic activity of imipramine and some analogs at muscarinic receptors of cultured mouse neuroblastoma cells (2004) (7)
- Rapid Degradation of Neurotensin by Intact Murine Neuroblastoma Cells (Clone N1E‐115) (1987) (7)
- Peptidic and Non-Peptidic Neurotensin Analogues (1998) (7)
- The prescriber's guide to classic MAO-inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. (2022) (7)
- Neurochemistry and neuropharmacology. (1988) (7)
- Alcohol and the elderly. Psychotropics and the elderly: interactions to watch for. (1984) (7)
- A single amino acid of the human and rat neurotensin receptors (subtype 1) determining the pharmacological profile of a species-selective neurotensin agonist. (2000) (7)
- Mechanisms of Action of Repetitive Transcranial Magnetic Stimulation (rTMS) and Vagus Nerve Stimulation (VNS) (2007) (7)
- Detection of peptide nucleic acids in tissue extracts of treated animals by gel mobility shift assay. (2000) (6)
- Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review. (1979) (6)
- Series on pharmacology in practice. 1. Drugs that alter mood. II. Lithium. (1979) (6)
- Studying neurotransmitter receptors: binding and biological assays. (1984) (6)
- A neurotensin analog blocks cocaine-conditioned place preference and reinstatement (2016) (6)
- Lithium ions inhibit function of lowbut not high-affinity muscarinic receptors of murine neuroblastoma cells (clone N1E-115) (1985) (6)
- Advances in medical management of overactive bladder. (2003) (5)
- Neurotensin receptor agonists and antagonists for schizophrenia. (2005) (5)
- Synaptic Effects of Antidepressants: Commentary (1996) (5)
- Serotonin: And what about its side effects? (1998) (5)
- Psychopharmacology of Schizophrenia: Past, Present, and Future (1990) (5)
- Tetranucleotide repeat polymorphism in the human neurotensin receptor (NT-R) gene. (2008) (5)
- Neurotensin Agonist Attenuates Nicotine Potentiation to Cocaine Sensitization (2014) (5)
- Basic neuropharmacology of antidepressants relevant to the pharmacotherapy of depression. (1999) (5)
- Effect of the antitumor drug caracemide on the neurochemistry of murine neuroblastoma cells (clone N1E-115). (1986) (4)
- Synthesis of partially non-peptidic neurotensin mimetics (1994) (4)
- Peptide nucleic acids targeted to the amyloid precursor protein (2007) (4)
- REGULATION OF CATECHOL SYNTHESIS IN AN ADRENERGIC CLONE OF MOUSE NEUROBLASTOMA (1973) (4)
- Novel Therapy for Nicotine Addiction in Alcohol Dependent Rats (2013) (4)
- Yohimbine- and tranylcypromine-induced postural hypotension. (1987) (3)
- Pyrrole-Based Partial Peptidic Mimic of Neurotensin (8-13): Design and Synthesis (Experimental Section) (2006) (3)
- Expression of mRNA for neurotensin in rat brain cholinergic neurons (1995) (3)
- Rational design of novel neurotensin mimetics: Discovery of a pharmacologically unprecedented agent exhibiting concentration-dependent dual effects as antagonist and full agonist (1994) (3)
- Effects of vitamin E on the fine structure of aggregating cell cultures (1978) (3)
- Psychotropic drugs and histamine H1-receptors of cultured mouse neuroblastoma cells. (1980) (3)
- Regulation of Neurotensin Receptor Expression and Function in a Neuronal Model System (1992) (3)
- Design, synthesis and pharmacological test of a quinoline based,nonpeptidic analogue of neurotensin(8–13) (1997) (3)
- Peptidic and Non-peptidic Neurotensin Analogs (1997) (2)
- Academic Highlights: Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression. [CME] (2007) (2)
- Antidepressants: effects on histaminic and muscarinic receptors (1983) (2)
- Neurotensin agonists in the regulation of food intake (2014) (2)
- A method to estimate in vivo D2 receptor occupancy by antipsychotic drugs. (1996) (2)
- Properties of tyrosine hydroxylation in living mouse neuroblastoma cells. Abstr. (1976) (2)
- NTS3 neurotensin receptor (2008) (2)
- NTS2 Neurotensin Receptor (2008) (2)
- Sodium-dependent lithium ion efflux from murine neuroblastoma and rat glioma cells: a minor pathway for efflux of lithium ions (1983) (2)
- Design, Synthesis and Pharmacological Evaluation of Active Pyrrole Based, Nonpeptidic Analogues of Neurotensin(8‐13). (1998) (2)
- RECEPTOR-MEDIATED CYCLIC GMP FORMATION BY AN ADRENERGIC CLONE (NIE-115) OF MOUSE NEUROBLASTOMA (1979) (1)
- Evidence of uncoupling of muscarinic receptor-effector complex during desensitization (1981) (1)
- Histamine (H1) receptor mediated cyclic GMP formation by mouse neuroblastoma cells (1978) (1)
- Evolving standards of antidepressant therapy (1991) (1)
- Erratum: Biological Basis of Depression and Therapeutic Relevance (The Journal of Clinical Psychiatry, June 1991 supplement, pp. 4-10) (1991) (1)
- The Pharmacology of Three Serotonin-Selective Drugs (1990) (1)
- Erratum: Chimeric rat/human neurotensin receptors localize a region of the receptor sensitive to binding of a novel, species-specific picomolar affinity peptide (Journal of Biological Chemistry (1996) 271 (15054-15059)) (1996) (1)
- Where are all the novel antidepressants? (2001) (1)
- Muscarinic Receptors: Molecular Biology and Neuropsychopharmacology (1992) (1)
- Effects of ethanol on prostaglandin e1 (pge1)-stimulated camp formation in mouse neuroblastoma cells. Abstr. (1977) (1)
- Psychedelic drugs for psychiatric disorders (2022) (1)
- Effects of Neurotensin Receptor Agonists, a Novel Class of Topical Analgesics, on Corneal Epithelial Cell Migration and Wound Healing (2008) (1)
- An NTS2 Analog Enhances the Analgesic Effects of Morphine in an Animal Model of Persistent Pain and Does not Exhibit Tolerance (2014) (1)
- Psychotropics and the elderly (1984) (1)
- Tricyclic antidepressants. Drugs for other diseases. (1982) (1)
- WITHDRAWN: Bioactive analogs of neurotensin (2005) (1)
- Desensitization of histamine H1 receptors on mouse neuroblastoma cells (1978) (1)
- JPET #165282 Title page Systemically and topically active antinociceptive neurotensin compounds (2010) (0)
- 201. Neuroleptics as antagonists and agonists of neurotransmitter receptors (1996) (0)
- P-19-9 The study of differentially expressed molecules in Alzheimer's disease brain (1996) (0)
- Triple reuptake inhibitors as a new generation of antidepressant drugs (2008) (0)
- 120. Mutational screening of NTR-1 in Schizophrenic patients by dideoxy fingerprinting (1998) (0)
- Psychotropic drugs, catecholamines, and nerve cultures. (1975) (0)
- 96-5 Neurotensin receptors in brain as targets for new neuropsychiatric drugs (1997) (0)
- Mesoridazine and thioridazine. (1987) (0)
- Pharmacological properties of tricyclic antidepressants and the treatment of somatic disorders. (1984) (0)
- P-20-12 The binding of some psychotropic drugs at the molecularly cloned human histamine H1 receptor expressed by CHO cells (1996) (0)
- Psychotropic drugs and nerve cell development (1979) (0)
- Design, Synthesis and Pharmacological Test of a Quinoline Based, Nonpeptidic Analogue of Neurotensin(8-13). (2010) (0)
- Neurohormone synthesis by different clones of neuroblastoma. Abstr. (1971) (0)
- 435. Pharmacokinetics of peptide nucleic acids after IV administration (2000) (0)
- Triple Reuptake Inhibitors: What to Expect from 'Mega-Antidepressants'; Rapid Onset of Action Could Make Serotonin-Norepinephrine-Dopamine Reuptake Blockers a Clinically Useful Option for Patients with Depression (2007) (0)
- Neurotransmitter Synthesis by Neuroblast (2016) (0)
- Expression of Neurotensin Receptors in the Corneal and Trigeminal Ganglion (2008) (0)
- 166. Development of a neurotensin agonist crossing the blood brain barrier (1998) (0)
- 121. Peptide nucleic acids delivered extracranially cross the blood brain barrier (1998) (0)
- The functional role of dopamine D1 receptors (1997) (0)
- Advances in the treatment of depression: Do we need to get physical? (2008) (0)
- Sleep and Mental Illness: Neuropharmacology of mental illness (2010) (0)
- Chronic treatment with paliperidone, like lithium and valproate, induces similar changes in expression and phosphorylation at the synaptoneurosomal level in rat prefrontal cortex (PFC) (2008) (0)
- Psychopharmacology of classical and atypical antipsychotics. (1991) (0)
- Synthesis of a Potent Wide‐Spectrum Serotonin‐, Norepinephrine‐, Dopamine‐Reuptake Inhibitor (SNDRI) and a Species‐Selective Dopamine‐Reuptake Inhibitor Based on the Gamma‐Amino Alcohol Functional Group. (1998) (0)
- Foreword (2000) (0)
- REGULATION OF NEUROTENSIN RECEPTOR BY RECEPTOR MEDIATED cGMP FORMATION IN N1E‐115 NEUROBLASTOMA CELLS (1992) (0)
- Muscarinic receptor function in cultured nerve cells: ion dependence and effects of local anesthetics (1977) (0)
- Brain Norepinephrine: Actions of antidepressant and other drugs on norepinephrine systems (2007) (0)
- Potent and Prolonged Analgesia in Intact Rabbit Cornea Using Synthetic Neurotensin Analogs (2008) (0)
- Differential effect of a lanthanide on binding of muscarinic receptor agonists and antagonists (1980) (0)
- Regulation of neurotensin receptor mRNA expression by neuroleptics in the rat midbrain dopaminergic neurons (1995) (0)
- Synthesis of Partial Nonpeptidic Peptide Mimetics as Potential Neurotensin Agonists and Antagonists. (1995) (0)
- In reply. (2013) (0)
- Neurochemical correlates of affective disorders and their treatment: Closing lecture (1990) (0)
- Subject Review Antidepressants: A Clinical Update for Medical Practitioners (1984) (0)
- Mood stabilizers VS. antipsychotics: Differences in mitochondrial migration (2010) (0)
- 434. Peptide nucleic acids targeted to the dopamine transporter alter behavior (2000) (0)
- Synthesis of (2S)‐2‐Amino‐3‐(1H‐4‐indolyl)propanoic Acid, a Novel Tryptophan Analogue for Structural Modification of Bioactive Peptides. (1999) (0)
- Neurotensin receptor agonists and antagonists for schizophrenia [13] (multiple letters) (2005) (0)
- Effects of emetic drugs on postprandial canine gastrointestinal motor activity (1981) (0)
- Short Report on DNA Marker at Candidate Locus (1997) (0)
- 537. The use of RNA fingerprinting technique in the neuropsychiatry research (1996) (0)
- Contents, Vol. 20, Supplement 1, 1987 (1987) (0)
- Synthesis of (S)- and (R)-Enantiomers of p-(4-Hydroxybenzoyl)phenylalanine, Useful Photoaffinity Labeling Probes for Peptide—Protein Binding Sites. (1998) (0)
- 2013 Daniel H. Efron Research Award (2012) (0)
- Quinacrine-Associated Mania: The authors reply (1989) (0)
- Lack of function of histamine H1 and muscarinic acetylcholine receptors of mouse neuroblastoma cells grown in serum-free medium (1982) (0)
- NEUROTENSIN FAILS TO AUGMENT THE EFFECT OF INDUCED MILD HYPOTHERMIA ON SURVIVAL AFTER HEMORRHAGIC SHOCK IN AWAKE RATS: 124 (2004) (0)
- Biological Psychiatry: Foreword (2000) (0)
- Co-localization of neurotensin receptor mRNA within dopaminergic neurons (1994) (0)
- Studies on lithium transport into cultured mouse neuroblastoma cells (1976) (0)
- Antipsychotic drugs block muscarinic acetylcholine receptor mediated formation of cyclic gmp in cultured mouse neuroblastoma cells. Abstr. (1977) (0)
This paper list is powered by the following services:
